Effects of the Novel Inhaled Phosphodiesterase-4 (PDE4) Inhibitor CHF6001 in Targeting Markers of Inflammation in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Authors :: Aida Emirova
Dave Singh
Marie Anna Nandeuil
Brendan Colgan
Germano Lucci
Oliver Kornmann
Brianr R. Leaker
Mirco Govoni
Silvia Geraci
Kai Michael Beeh
E. Calabro Rocco
Henrik Watz
Source :: D101. CLINICAL AND TRANSLATIONAL STUDIES IN ASTHMA AND COPD.
Publication Year :: 2019
Publisher :: American Thoracic Society, 2019.

Subjects :: Moderate to severe
medicine.medical_specialty
Chronic bronchitis
COPD
business.industry
Pulmonary disease
Inflammation
medicine.disease
Gastroenterology
Phosphodiesterase-4
Internal medicine
medicine
In patient
medicine.symptom
business

Tools